The growth of cleanroom technology is majorly driven by the rising demand for sterilized pharmaceutical formulations, increasing demand for medical devices. The technological advancements in cleanroom technology along with the increasing demand for cleanroom technologies in developing economies are expected to offer significant opportunities for market growth in the coming years.
The technical limitations associated with their operational costs and technical challenges associated with the customization of cleanroom designs in developing economies are hindering the growth of this market to a certain extent.
The biopharmaceutical industry has witnessed the emergence of a new class of therapeutics showing significant potential in new treatments in oncology, diabetes, and other disease areas. Currently, there are hundreds of monoclonal antibodies, vaccines, and biologics in clinical development. The faster approval of new drugs drives the demand for cleanrooms for their manufacturing.